EZMEKLY caps 2 mg 42 pce

7680703870020 CH-70387 L01EE05 07.16.1.

Active substances:

No images available

Details

Product number
7038702
CPT
-
Packaging group
42
Unit
Kapsel(n)
Composition
mirdametinibum 2 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum), E 133, Drucktinte: lacca, propylenglycolum, aqua purificata, kalii hydroxidum, E 171, pro capsula corresp. natrium max. 1.2 mg.

Articles (1)

Ezmekly 2 mg, Hartkapseln
Kapseln
42
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
18/04/2026
Professional SmPC
Français
18/04/2026
Professional SmPC
Italien
18/04/2026
Patient information leaflet
Allemand
17/04/2026
Patient information leaflet
Français
17/04/2026
Patient information leaflet
Italien
17/04/2026

Detailed composition

Substance Quantity Type Category
mirdametinibum
2.0 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
E 133
- Substance FIMDK
lacca
- Substance HNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
aqua purificata
- Substance HNIDK
kalii hydroxidum
- Substance HNIDK
E 171
- Substance FNIDK
natrium
- Substance HBESI

Reimbursement information

Public price
CHF 10006.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2026

Authorization holder

Merck (Schweiz) AG

6300 Zug

Authorization information

Swissmedic authorization number
70387
Drug name
Ezmekly, Hartkapseln
Galenic form
KAHA
ATC Code
L01EE05
Authorization status
B
Dispensation category
A
First authorization
09/04/2026
Authorization expiration date
09/04/2028
IT number
07.16.1.
Domain
Human medicine
Field of application
Symptomatische und inoperable plexiforme Neurofibrome bei Patienten mit Neurofibromatose Typ 1 (NF1).

Packaging details

Description (FR)
EZMEKLY caps 2 mg 42 pce
Description (DE)
EZMEKLY Kaps 2 mg 42 Stk
Market launch
08/06/2026
Narcotic (BTM)
No

Other packaging sizes

EZMEKLY caps 1 mg 42 pce
42 KAP
View
Buy us a coffee Explore the data